Stuart C. Wilson
- Co-authors
- Paul WorkmanVassilios BavetsiasAnn L. JackmanDavinder S. ThetiAmin MirzaPhilip W. HowardMike I. WaltonIan R. Hardcastle
- Topics
- Cancer-related Molecular Pathways (7 papers)Advanced Breast Cancer Therapies (6 papers)Cancer therapeutics and mechanisms (3 papers)
- Partner nations
- United KingdomUnited States
In The Last Decade
Stuart C. Wilson
14 papers receiving 545 citations
Peers
Comparison fields: 5 of 73
- Molecular Biology 305
- Organic Chemistry 208
- Oncology 147
- Cell Biology 94
- Pulmonary and Respiratory Medicine 53
Countries citing papers authored by Stuart C. Wilson
This map shows the geographic impact of Stuart C. Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart C. Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart C. Wilson more than expected).
Fields of papers citing papers by Stuart C. Wilson
This network shows the impact of papers produced by Stuart C. Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart C. Wilson. The network helps show where Stuart C. Wilson may publish in the future.
Co-authorship network of co-authors of Stuart C. Wilson
This figure shows the co-authorship network connecting the top 25 collaborators of Stuart C. Wilson. A scholar is included among the top collaborators of Stuart C. Wilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart C. Wilson. Stuart C. Wilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 31 | |
| 2 | 86 | |
| 3 | 26 | |
| 4 | Abstract #3863: Derivatives of seliciclib with improved potency both in vitro and in vivo as novel cyclin dependent kinase (CDK) inhibitors | 1 |
| 5 | Novel cyclin dependent kinase (CDK) inhibitors induce down regulation of Mcl-1 and apoptosis in multiple myeloma cells | 1 |
| 6 | 123 | |
| 7 | 47 | |
| 8 | 25 | |
| 9 | Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor R-roscovitine in the mouse. | 58 |
| 10 | 56 | |
| 11 | 25 | |
| 12 | 5 | |
| 13 | 62 | |
| 14 | 9 |
About Stuart C. Wilson
Stuart C. Wilson is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Organic Chemistry, having authored 14 papers that have together received 555 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (7 papers), Advanced Breast Cancer Therapies (6 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Organic Chemistry (208 citations), Cell Biology (94 citations) and Oncology (147 citations). Stuart C. Wilson has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Paul Workman, Vassilios Bavetsias, Ann L. Jackman, Davinder S. Theti, Amin Mirza, Philip W. Howard, Mike I. Walton, Ian R. Hardcastle, David E. Thurston and Peter M. Fischer. Their work appears in journals such as PLoS ONE, Cancer Research and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.